« Back
Home /
Partner: BIOSERV Diagnostics |Hölzel Diagnostika

BIOSERV Diagnostics

Bioserv Diagnostics

BIOSERV Diagnostics is a member of R-biopharm Group, Germany.

Bioserv Diagnostics is a reliable partner for development, production and worldwide marketing of in-vitro diagnostics. The core competence of BIOSERV Diagnostics lies in products for the diagnosis of gastroenterological and fertility disorders.

BIOSERV Diagnostics specializes in developing and producing tests that can detect functional and organic disorders. The product line encompasses in particular ELISA kits, but also latex agglutination and haemagglutination tests. These easy to use products allow laboratories to achieve reliable test results quickly and cost-effectively.

The headquarters of BIOSERV Diagnostics are situated in Rostock and Greifswald, both harbour cities and sea-side resorts on the coast of the Baltic Sea in the north-eastern federal state of Mecklenburg Western-Pomerania, about 2 hours by car or by train from either Hamburg or Berlin.

For more than 17 years now BIOSERV develops and produces ready-to-use diagnostic kits to meet the needs of the world's markets. Our laboratories, supplied with state of the art equipment, develop and produce in-vitro test kits complying with the highest international standards.

All products manufactured and sold by BIOSERV Diagnostics bear the CE-mark. The customers can be confident that they will only get accurately manufactured and optimized quality products. Bioserv Diagnostics working processes strictly follow the guidelines of DIN EN ISO 13485 : 2003 + Cor. 1 : 2009 The requirements of the IVD-guideline 98/79/EEC are also considered thereby.

There are ready-to-use diagnostic kits from BIOSERV Diagnostics for gastroenterology, fertility and risk pregnancy monitoring.

For example sperm antibody ELISA for use with seminal plasma. This is a quantitative ELISA for the detection of anti-sperm antibodies (anti-spermatozoa antibodies, sperm antibodies). This anti-sperm ELISA has been optimized for the detection of anti-sperm antibodies in human seminal plasma.

And the Anti-zona pellucida-antibody ELISA. This test is designed to quantify antibodies directed against zona pellucida (ZP) antigens. Application is recommended for all female patients showing fertility disorders of unknown aetiology or ovary malfunctions as well as in preparation for assisted reproduction therapy.